Surprisingly, a study indicated that bispecific Trop2/PDL1 CAR-T cells could significantly inhibit gastric cancer growth by intratumoral injection, and its inhibitory effect was more significant than that of Trop2-specific CAR-T cells [57]. This evidence concerns the gene TACSTD2 and gastric cancer.